RZLT vs. SMMT
RZLT (Rezolute, Inc.) and SMMT (Summit Therapeutics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, RZLT returned -20.19%/yr vs 6.40%/yr for SMMT. Their 0.07 correlation means their historical movements had little consistent relationship.
Performance
RZLT vs. SMMT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RZLT achieves a 100.00% return, which is significantly higher than SMMT's -25.56% return. Over the past 10 years, RZLT has underperformed SMMT with an annualized return of -20.19%, while SMMT has yielded a comparatively higher 6.40% annualized return.
RZLT
- 1D
- -3.28%
- 1M
- -3.87%
- 6M
- 41.32%
- YTD
- 100.00%
- 1Y
- -19.59%
- 3Y*
- 38.67%
- 5Y*
- -15.77%
- 10Y*
- -20.19%
- ALL TIME*
- -26.35%
SMMT
- 1D
- -3.12%
- 1M
- -15.56%
- 6M
- -10.08%
- YTD
- -25.56%
- 1Y
- -51.90%
- 3Y*
- 84.00%
- 5Y*
- 12.18%
- 10Y*
- 6.40%
- ALL TIME*
- 2.32%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
RZLT Rezolute, Inc. | $5.67M | $6.97M | $7.94M |
| $58.74M | $54.76M | $76.18M |
RZLT vs. SMMT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RZLT Rezolute, Inc. | 100.00% | -51.84% | 393.70% | -52.05% | -56.69% | -60.13% | 108.52% | 27.78% | -89.83% | -11.50% |
SMMT Summit Therapeutics Inc. | -25.56% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
Correlation
The correlation between RZLT and SMMT is 0.20, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.20 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.08 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2015 | 0.07 |
The correlation between RZLT and SMMT shifts across timeframes, from 0.07 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
RZLT:
$454.50M
SMMT:
$10.11B
RZLT:
-$0.79
SMMT:
-$1.12
RZLT:
4.20
SMMT:
16.08
RZLT:
$0.00
SMMT:
$0.00
RZLT:
-$15.00K
SMMT:
$0.00
RZLT:
-$67.00M
SMMT:
-$640.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RZLT vs. SMMT — Risk / Return Rank
RZLT
SMMT
RZLT vs. SMMT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rezolute, Inc. (RZLT) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RZLT | SMMT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.53 | ||
| Sortino ratioReturn per unit of downside risk | +2.13 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 0.90 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | -0.24 | -0.89 | +0.65 |
| Martin ratioReturn relative to average drawdown | -0.38 | -1.28 | +0.90 |
Loading charts...
Drawdowns
RZLT vs. SMMT - Drawdown Comparison
The maximum RZLT drawdown since its inception was -99.63%, roughly equal to the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for RZLT and SMMT.
Loading charts...
Drawdown Indicators
| RZLT | SMMT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.63% | -95.75% | -3.88% |
Max Drawdown (1Y)Largest decline over 1 year | -87.20% | -57.20% | -30.00% |
Max Drawdown (3Y)Largest decline over 3 years | -87.20% | -65.80% | -21.40% |
Max Drawdown (5Y)Largest decline over 5 years | -93.50% | -91.78% | -1.72% |
Max Drawdown (10Y)Largest decline over 10 years | -99.16% | -95.75% | -3.41% |
Current DrawdownCurrent decline from peak | -97.64% | -64.52% | -33.12% |
Average DrawdownAverage peak-to-trough decline | -87.13% | -57.66% | -29.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.84% | 39.51% | +15.33% |
Volatility
RZLT vs. SMMT - Volatility Comparison
Rezolute, Inc. (RZLT) has a higher volatility of 22.71% compared to Summit Therapeutics Inc. (SMMT) at 20.05%. This indicates that RZLT's price experiences larger fluctuations and is considered to be riskier than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RZLT | SMMT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.71% | 20.05% | +2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 57.06% | 56.28% | +0.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 126.83% | 73.60% | +53.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.01% | 185.17% | -90.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 160.50% | 144.56% | +15.94% |
Dividends
RZLT vs. SMMT - Dividend Comparison
Neither RZLT nor SMMT has paid dividends to shareholders.
Financials
RZLT vs. SMMT - Financials Comparison
This section allows you to compare key financial metrics between Rezolute, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RZLT and SMMT have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RZLT has higher volatility (22.71%) compared to SMMT (20.05%). In terms of maximum drawdown, RZLT dropped -99.63% vs SMMT's -95.75%.
RZLT currently has the higher Sharpe Ratio (-0.16 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RZLT and SMMT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer